Senior Manager, Customer Engagement Platforms

Copenhagen, Denmark

Auto‑apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree in Business, Marketing, IT, or a related field, with an advanced degree preferred. They must have at least 5 years of proven experience in CRM management, specifically with Salesforce and Projectum’s PPM tool. Strong strategic planning and business case development skills are required, alongside excellent leadership and team development capabilities. Furthermore, experience with global team management and expansion is necessary.

Responsibilities

As a Senior Manager, Customer Engagement Platforms, the individual will lead the implementation of Salesforce and Projectum’s PPM tool solutions globally, collaborating with departments such as Marketing, Business Development, Project Management, and Finance to digitalize the value chain. They will develop and execute strategies for IT transformation, build business cases to support these initiatives, and engage in hands-on execution of Digital Customer Engagement activities. The role also involves developing and nurturing the team, ensuring effective collaboration and performance, expanding team operations in the US and Japan, and working closely with business and vendor stakeholders to implement the system while managing customer expectations and prioritizing multiple projects simultaneously.

Skills

Business Application Management

Salesforce

Projectum PPM

Data Integrity

Process Modelling

Digital Transformation

Team Leadership

Strategic Planning

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters

2001Year Founded

$613MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.

Leadership changes may disrupt ongoing projects and affect client trust.

Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.

The company offers fast-track project capabilities for orphan drugs and rare diseases.

AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.

Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.

Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI

Try Jobo Free